AbbVie is a global biopharmaceutical company with a workforce of roughly 26,500 employees. Recent hiring added about 2,600 people, while departures totaled just over 1,300, resulting in net headcount growth. This balanced expansion suggests ongoing investment in research, commercial operations, and corporate infrastructure to support its drug portfolio and pipeline.
Engineering is AbbVie’s largest function, employing more than 5,100 people—nearly one-fifth of the total workforce—underscoring the company’s emphasis on process development and manufacturing excellence. Sales and Support follows closely with 4,800 employees, reflecting the scale needed to commercialize and service its therapies. Business Management, Healthcare, and Marketing & Product each exceed 2,700 employees, together accounting for about one-third of overall staff and providing critical leadership, clinical expertise, and market enablement. Operations, Finance & Administration, Human Resources, and Information Technology round out the organization, supporting day-to-day business needs and specialized services.
Headquarters operations in the greater Chicago area employ roughly 5,400 people, making it AbbVie’s largest talent hub. Additional U.S. clusters include New York, Boston, Irvine, San Francisco, Los Angeles, Kenosha, and Austin, each ranging between about 170 and 620 employees. Outside the United States, Ireland is the most significant international location with just under 300 team members. A distributed group of more than 1,300 employees works from other sites worldwide, illustrating AbbVie’s geographically diverse footprint designed to reach patients and partners across multiple regions.